Furthermore, a latest study reported that LRG1 was associated with CRP, ESR, and traditional biomarkers, but remained high despite suppression of CRP and ESR in RA patients receiving IL-6 inhibitor [24]. This evidence concerns the gene CRP and rheumatoid arthritis.